Try our Advanced Search for more refined results
June 21, 2017
Omeros Corporation v. Sandoz Inc.
Case Number:
1:17-cv-00799
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 27, 2018
Sandoz Holds Back On Cataract Drug Generic, Ending IP Suit
Sandoz Inc. has agreed to hold off on its generic version of Omeros Corp.'s cataract surgery drug Omidria until related patents expire in 15 years, putting an end to infringement litigation in Delaware federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login